A longitudinal tau PET study running in ageing and AD subjects by Clifford Jack et al. showed that the rate measurements based on Braak topographic staging of NFTs or voxel-wise approaches may not necessarily provide substantially more information than simple meta-ROI rate measurements. This evidence concerns the gene MAPT and Alzheimer disease.